Plasma Growth Differentiation Factor-15 as a Prognostic Biomarker in Children with Congestive Heart Failure
Abrar Mohamed Khayal, Shimaa Basyoni El- Nemr, Hesham Ahmed El- Serogy, Amr Mohamed Zoair
Journal of Advances in Medicine and Medical Research · pp. 34–42 · Published 23 Nov 2020
10.9734/jammr/2020/v32i2230703Abstract
Aim and Objectives: This study aimed to evaluate the plasma levels of Growth Differentiation Factor-15 (GDF-15) in children with congestive heart failure, also to evaluate the diagnostic and prognostic value of this novel biomarker in pediatric congestive heart failure, by correlation of its levels with the clinical status and the echocardiographic data of these patients. Subjects and Methods: This study was conducted on Thirty (30) children with congestive heart failure (CHF), Patients were selected from those admitted to Pediatric Cardiology Unit, Pediatric Department, Tanta University Hospital, from (August 2018-April 2020), and thirty (30) healthy children, matched for age and sex, were enrolled as a control group. All children in this study were subjected to Plain X-ray chest and heart: Cardiothoracic ratio (CTR) was measured, and Echocardiographic assessment: Doppler and Two-dimensional, M-mode Echocardiographic evaluation of these parameters and Plasma level of Growth Differentiation Factor-15 (GDF-15) was measured. Results: the results revealed that The best cutoff point of GDF-15 to differentiate between cases with CHF and control group was >446.5 ng/l with 93.33% sensitivity, 90% specificity, 90.3% PPV, 93.1% NPV and AUC was 0.992. There was significant decrease of EF% and FS% (systolic dysfunction of LV) in patients with CHF as compared to control group. There was statistically significant positive correlation between plasma level of GDF-15 and Ross clinical stage of CHF. There was statistically significant negative correlation between GDF-15 and EF%, FS % by echocardiography. Conclusion: Plasma levels of GDF-15 were elevated in children with CHF, and these levels were correlated to the Ross staging of CHF and echocardiographic assessment of LV function. Plasma levels of GDF-15 were elevated in patients with bad prognosis, denoting its prognostic value as a novel biomarker in pediatric CHF.
Cited by 1
1 citation reported by external sources — individual citing-article records aren't available to list yet.
Related research
- Differential Gene Expression Analysis and Biomarker Identification for Colorectal Cancer — shares topic coverage
- Dengue Vaccines, Antiviral Therapeutics and Emerging Diagnostic Biomarkers: Advances, Constraints and Translational Priorities — shares topic coverage
- Integrative Bioinformatics Analysis of microRNA Expression and Genomic Signatures for Early Detection and Survival Prediction in Prostate Cancer — shares topic coverage
- Study of Serum Magnesium Abnormalities in Congestive Heart Failure — shares topic coverage
- Impact of Ayurveda-based Panchkarma Therapy in Change of the VO2peak in Congestive Heart Failure Patients - An Observational Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.